Epstein-Barr Virus (EBV) infection in Chinese children: A retrospective study of age-specific prevalence

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Xiong, Geng ^a   Zhang, Bo ^b   Huang, Mu Yun ^a   Zhou, Hufeng ^c,d   Chen, Li Zhen ^a   Feng, Qi Sheng ^a   Luo, Xi ^e   Lin, Hui Jia ^f   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CANCER HOSPITAL   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Guangzhou Women and Children's Medical Center   (China)

^f GUANGDONG WOMEN AND CHILDREN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGE; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHILD; CHINESE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROPREVALENCE; ANTIBODY SPECIFICITY; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DEMOGRAPHY; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; IMMUNOLOGY; INFANT; NEWBORN; PHYSIOLOGY; PREVALENCE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ANTIBODY SPECIFICITY; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHINA; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84902576948     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099857     Document Type: Article

References (28)

1. de The G, Day N, Geser A, Ho JH, Simons MJ, et al. (1975) Epidemiology of the Epstein-Barr virus infection and associated tumors in man. Bibliotheca haematologica: 216-220.
2. Thompson MP, Kurzrock R (2004) Epstein-Barr virus and cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 10: 803-821.
3. Raab-Traub N, Webster-Cyriaque J (1997) Epstein-Barr virus infection and expression in oral lesions. Oral diseases 3 Suppl 1: S164-170. (Pubitemid 27242085)
4. Wang X, Kenyon WJ, Li Q, Mullberg J, Hutt-Fletcher LM (1998) Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. Journal of virology 72: 5552-5558. (Pubitemid 28283338)
5. Cao SM, Simons MJ, Qian CN (2011) The prevalence and prevention of nasopharyngeal carcinoma in China. Chinese journal of cancer. 2011;30: 114-9.
6. Murata T, Sato Y, Kimura H (2014) Modes of infection and oncogenesis by the Epstein-Barr virus. Reviews in medical virology.
7. Balfour HH, Jr., Verghese P (2013) Primary epstein-barr virus infection: impact of age at acquisition, coinfection, and viral load. The Journal of infectious diseases 207: 1787-1789.
8. Macsween KF, Crawford DH (2003) Epstein-Barr virus-recent advances. The Lancet infectious diseases 3: 131-140.
9. Bagni R, Whitby D (2012) Age of infection and risk of virally associated cancers: new clues to an old puzzle. The Journal of infectious diseases 205: 873-874.
10. de-The G, Geser A, Day NE, Tukei PM, Williams EH, et al. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756-761. (Pubitemid 8406152)
11. Adams M, Jasani B, Fiander A (2007) Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine 25: 3007-3013. (Pubitemid 46482732)
12. Pearson GR (1988) ELISA tests and monoclonal antibodies for EBV. Journal of virological methods 21: 97-104.
13. Rea TD, Ashley RL, Russo JE, Buchwald DS (2002) A systematic study of Epstein-Barr virus serologic assays following acute infection. American journal of clinical pathology 117: 156-161. (Pubitemid 34052486)
14. Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, et al. (2003) Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. Journal of medical virology 70: 617-623. (Pubitemid 36734728)
15. Hess RD (2004) Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. Journal of clinical microbiology 42: 3381-3387.
16. Koidl C, Riedl R, Schweighofer B, Fett S, Bozic M, et al. (2011) Performance of new enzyme-linked fluorescent assays for detection of Epstein-Barr virus specific antibodies in routine diagnostics. Wiener klinische Wochenschrift 123: 230-234.
17. Bauer G (2001) Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clinical laboratory 47: 223-230.
18. Dowd JB, Palermo T, Brite J, McDade TW, Aiello A (2013) Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PloS one 8: e64921.
19. Balfour HH, Jr., Sifakis F, Sliman JA, Knight JA, Schmeling DO, et al. (2013) Age-specific prevalence of Epstein-Barr virus (EBV) infection among children in the United States and factors affecting its acquisition. The Journal of infectious diseases 208: 1286-1293.
20. Morris MC, Edmunds WJ, Hesketh LM, Vyse AJ, Miller E, et al. (2002) Seroepidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. Journal of medical virology 67: 522-527. (Pubitemid 34747671)
21. Huang Y, Wei C, Zheng K, Zhao D (2013). The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections. Virology journal 10: 55.
22. Hjalgrim H, Friborg J, Melbye M (2007) The epidemiology of EBV and its association with malignant disease. In: A . Arvin, G. Campadelli-Fiume, E. Mocarski, PS. Moore, B. Roizman, R. Whitley and K. Yamanishi, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge.
23. Gao Y, Lu YJ, Xue SA, Chen H, Wedderburn N, et al. (2002) Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus. Oncogene 21: 825-835. (Pubitemid 34146294)
24. Zou X, Li J, Lu S, Song X, Wang X, et al. (1992) Volatile N-nitrosamines in salted fish samples from high- and low-risk areas for NPC in China. Chinese medical sciences journal 7: 201-204. (Pubitemid 23022655)
25. Zou XN, Lu SH, Liu B (1994) Volatile N-nitrosamines and their precursors in Chinese salted fish - a possible etological factor for NPC in china. International journal of cancer Journal 59: 155-158.
26. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, et al. (2005) Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. Journal of virology 79: 15323-15330.
27. Liu P, Fang X, Feng Z, Guo YM, Peng RJ, et al. (2011) Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. Journal of virology 85: 11291-11299.
28. Cohen JI, Mocarski ES, Raab-Traub N, Corey L, Nabel GJ (2013) The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine 31 S